Illinois Honors Lilly for Maternal Health Advocacy

State Representative Camille Lilly was recognized at a maternal health roundtable at Rush Oak Park Hospital.

Updated on Nov. 14, 2026 in Lifestyle

Illinois Honors Lilly for Maternal Health Advocacy

Live Poll

Do you support insurance covering pregnancy testing without out-of-pocket costs?

Illinois State Representative Camille Lilly was recognized Thursday at a Maternal Health and Prematurity Awareness Roundtable held at Rush Oak Park Hospital. Lilly sponsored House Bill 3706, which expanded private insurance coverage for preeclampsia biomarker testing.

Why it matters

Biomarker testing identifies pregnancy risks earlier, and Illinois is now the first state to mandate coverage for preeclampsia biomarker testing across Medicaid and private insurance without patient cost-sharing. The change aims to address preeclampsia, a pregnancy complication whose rates are reported to be 60% higher among Black women than in the general population.

Preeclampsia rates among Black women are reported to be 60% higher than in the general population. The extraction does not report patient counts or outcome data for the new coverage mandates.

The players

Camille Lilly

Illinois State Representative who sponsored House Bill 3706 expanding private insurance coverage for preeclampsia biomarker testing.

Rush Oak Park Hospital

Oak Park hospital that hosted the Maternal Health and Prematurity Awareness Roundtable.

The details

The bills mandate insurance coverage for preeclampsia biomarker testing without patient cost-sharing, with Medicaid coverage included in Senate Bill 3365, an omnibus Medicaid package. Lilly was recognized at the roundtable, which marked Prematurity Awareness Month in November.

Timeline

  1. Earlier in 2026: House Bill 3706 expanded private insurance coverage for biomarker testing.

  2. Thursday, November 2026: Lilly was recognized at the roundtable held at Rush Oak Park Hospital.

Health Landscape

Illinois is the first state to mandate coverage for preeclampsia biomarker testing across Medicaid and private insurance without patient cost-sharing, extending House Bill 3706 and Senate Bill 3365. The move positions Illinois ahead of other states on this specific coverage requirement.

Illinois residents covered by Medicaid or private insurance may be able to access preeclampsia biomarker testing without paying out-of-pocket cost-sharing. Expectant patients can ask their providers whether the test is appropriate for their pregnancy.

The takeaway

Earlier identification of pregnancy risks through biomarker testing may help patients and providers plan care sooner. Anyone with coverage questions should contact their insurer to confirm how the new mandates apply to their plan.

Further reading

Explore more on Pregnancy to see how biomarker testing and prenatal care are discussed across the state.

Source note: This article includes information reported by Chicago Tribune.

Live Poll

Do you support insurance covering pregnancy testing without out-of-pocket costs?